Vascular endothelial growth factor antisense oligonucleotides inhibit leptomeningeal metastasis in vivo

Medical Oncology

Volumn 28, Issue 4, 2011, Pages 1116-1122

  Li, Kangan ^a   Zhang, Guixiang ^a   Zhao, Jinglong ^a   Wang, Xifu ^a   Li, Yujie ^a   Hu, Yunsheng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Antisense; DCE MRI; Leptomeningeal metastasis; VEGF; VX2 cells

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL GROWTH FACTOR ANTISENSE OLIGONUCLEOTIDE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOMATOUS MENINGITIS; CEREBROSPINAL FLUID; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL RABBIT; HISTOPATHOLOGY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; METASTASIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMAGE ENHANCEMENT; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MENINGEAL CARCINOMATOSIS; OLIGONUCLEOTIDES, ANTISENSE; RABBITS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84655176581     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9580-6     Document Type: Article

References (23)

1. LM DeAngelis D Boutros 2005 Leptomeningeal metastasis Cancer Invest 23 2 145 154
2. WR Wasserstrom JP Glass JB Posner 1982 Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients Cancer 49 4 759 772
3. WA Bleyer TN Byrne 1988 Leptomeningeal cancer in leukemia and solid tumors Curr Probl Cancer 12 4 181 238
4. M Watanabe R Tanaka N Takeda 1993 Correlation of MRI and clinical features in meningeal carcinomatosis Neuroradiology 35 7 512 515
5. BW Ongerboer de Visser R Somers WH Nooyen P van Heerde AA Hart JG McVie 1983 Intraventricular methotrexate therapy of leptomeningeal metastasis from breast carcinoma Neurology 33 12 1565 1572
6. JA Frank M Girton AJ Dwyer DC Wright PJ Cohen JL Doppman 1988 Meningeal carcinomatosis in the VX2 rabbit tumor model: detection with Gd-DTPA-enhanced MR imaging Radiology 167 3 825 829
7. PL Choyke AJ Dwyer MV Knopp 2003 Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging J Magn Reson Imaging 17 5 509 520
8. G Neufeld T Cohen S Gengrinovitch Z Poltorak 1999 Vascular endothelial growth factor (VEGF) and its receptors FASEB J 13 1 9 22
9. J Drevs I Hofmann H Hugenschmidt C Wittig H Madjar M Muller J Wood G Martiny-Baron C Unger D Marme 2000 Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model Cancer Res 60 17 4819 4824
10. RA Brekken JP Overholser VA Stastny J Waltenberger JD Minna PE Thorpe 2000 Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice Cancer Res 60 18 5117 5124
11. ZP Gu YJ Wang JG Li YA Zhou 2002 VEGF165 antisense RNA suppresses oncogenic properties of human esophageal squamous cell carcinoma World J Gastroenterol 8 1 44 48
12. J Miree Jr S Gold 1973 Relationship of survival with number of V-2 carcinoma cells implanted in the subarachnoid space of rabbits J Natl Med Assoc 65 5 407 409
13. SJ Goldsmith L Kostakoglu 2000 Role of nuclear medicine in the evaluation of the solitary pulmonary nodule Semin Ultrasound CT MR 21 2 129 138
14. RA Soslow AJ Dannenberg D Rush BM Woerner KN Khan J Masferrer AT Koki 2000 COX-2 is expressed in human pulmonary, colonic, and mammary tumors Cancer 89 12 2637 2645
15. SJ Gwyther 2005 New imaging techniques in cancer management Ann Oncol 16 Suppl 2 ii63 70
16. Y Feng EK Jeong AM Mohs L Emerson ZR Lu 2008 Characterization of tumor angiogenesis with dynamic contrast-enhanced MRI and biodegradable macromolecular contrast agents in mice Magn Reson Med 60 6 1347 1352
17. T Barrett M Brechbiel M Bernardo PL Choyke 2007 MRI of tumor angiogenesis J Magn Reson Imaging 26 2 235 249
18. QG de Lussanet S Langereis RG Beets-Tan MH van Genderen AW Griffioen JM van Engelshoven WH Backes 2005 Dynamic contrast-enhanced MR imaging kinetic parameters and molecular weight of dendritic contrast agents in tumor angiogenesis in mice Radiology 235 1 65 72
19. A Preda M van Vliet GP Krestin RC Brasch CF van Dijke 2006 Magnetic resonance macromolecular agents for monitoring tumor microvessels and angiogenesis inhibition Invest Radiol 41 3 325 331
20. KP Claffey LF Brown LF del Aguila K Tognazzi KT Yeo EJ Manseau HF Dvorak 1996 Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis Cancer Res 56 1 172 181
21. HT Zhang P Craft PA Scott M Ziche HA Weich AL Harris R Bicknell 1995 Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells J Natl Cancer Inst 87 3 213 219
22. HG Hotz OJ Hines R Masood B Hotz T Foitzik HJ Buhr PS Gill HA Reber 2005 VEGF antisense therapy inhibits tumor growth and improves survival in experimental pancreatic cancer Surgery 137 2 192 199
23. GR Ruan YR Liu SS Chen JY Fu Y Chang YZ Qin JL Li H Yu H Wang 2004 Effect of antisense VEGF cDNA transfection on the growth of chronic myeloid leukemia K562 cells in vitro and in nude mice Leuk Res 28 7 763 769